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conventions and reporting standards for valida-
tion in 3DEM, as part of the Electron Microscopy 
Validation Task Force (EM-VTF)4. Developers 
of several major EM software packages, includ-
ing Appion5, Bsoft6, EMAN2 (ref. 7), EMEN2 
(http://blake.bcm.edu/emanwiki/EMEN2/), 
IMOD8, MRC9 and Xmipp10, also participated. 
M.W. represented two UK-based Collaborative 
Computational Projects (http://www.ccp.ac.uk/), 
namely the well-established Collaborative 
Computational Project Number 4 (CCP4)11 for 
macromolecular crystallo graphy and the newly 
formed Collaborative Computational Project 
validating and annotating 3DEM data, PDBe 
and the Open Microscopy Environment (OME) 
organized a workshop, Data Management 
Challenges in 3D Electron Microscopy 
(DMCEM) at Hinxton Hall, Wellcome Trust 
Genome Campus, Cambridge, UK on 5 and 6 
December 2011.
Participants included experts with estab-
lished pipelines for 3DEM data collection and 
processing and thus brought valuable expertise 
on the data-management challenges facing the 
field. Several participants have been involved in 
community-wide initiatives to define  standards, 
The EMDataBank (http://www.emdatabank.
org/)1 is an organization that runs a global 
deposition and retrieval network for three-
dimensional EM (3DEM) maps, molecular 
models and associated metadata. It consists 
of three partners, the Protein Data Bank in 
Europe (PDBe), the Research Collaboratory 
for Structural Bioinformatics (RCSB PDB) 
and the National Center for Macromolecular 
Imaging (NCMI). The EMDataBank manages 
the Electron Microscopy Data Bank (EMDB)2, 
the global archive of 3DEM data that now holds 
over 1,500 maps and thus offers a unique per-
spective on the state and development of the 
3DEM field. The field has experienced rapid 
growth in recent years, as witnessed by rapidly 
increasing numbers of publications and 3DEM-
derived structures archived in the EMDB. In 
addition, the number and size of images used 
to derive maps has been increasing steadily, 
driven by the quest for higher resolution, and 
these trends are likely to continue (Fig. 1). 
A bird’s-eye view on the trends and practices 
in the 3DEM field can be obtained through the 
EMstats service3 (http://pdbe.org/emstats/).
To discuss the growing challenges of stor-
ing, sharing, transferring, analyzing, viewing, 
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This report describes the outcomes of the Data Management Challenges in 3D Electron Microscopy workshop. Key topics 
discussed include data models, validation and raw-data archiving. The meeting participants agreed that the EMDataBank should 
take the lead in addressing these issues, and concrete action points were agreed upon that will have a substantial impact on the 
accessibility of three-dimensional EM data in biology and medicine.
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Figure 1  Trends in 3DEM. The cumulative number of released maps in the EMDB and 3DEM-derived 
models in the PDB are shown as a function of time.
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 experiment or their interpretation in terms of 
a volumetric or atomic model. Validation is 
essential to provide confidence in the interpre-
tation of the data in a molecular or cellular bio-
logical context. There are four essential aspects 
to single-particle 3DEM validation, namely 
ensuring the quality of the final map, verifying 
the claimed resolution, assessing the fit of any 
models to the map and assessing the quality of 
the models themselves.
Tilt-pair analysis17,18 has proven to be a 
valuable tool for establishing the overall qual-
ity of a map, and the tilt-pair validation server 
developed by the Rosenthal group (https://
cryoem.nimr.mrc.ac.uk/software/) has made 
the method generally accessible. To encour-
age use of this technique, the EMDataBank 
will collaborate with the Rosenthal group to 
incorporate support for tilt-pair validation into 
the new EMDB data model and to migrate the 
server to the PDBe website in preparation for 
its eventual integration as a validation tool in 
the D&A pipeline.
A.R. suggested that comparing small-angle 
X-ray scattering (SAXS)19 profiles with simu-
lated SAXS profiles generated from EM maps 
would be another means of establishing the 
overall correctness of the map20. It was agreed 
D&A system has prompted the design of a new 
EMDB data model that will capture the impor-
tant aspects of the various 3DEM methodologies 
(such as single-particle analysis, tomography, 
two-dimensional (2D) crystallography, etc.) and 
be sufficiently flexible to adapt to changes and 
as-yet-unforeseen future developments.
The data model is implemented and main-
tained in an Extensible Markup Language 
(XML) schema for which there exists a variety 
of powerful, industry-standard modeling tools. 
The high level of visual abstraction afforded by 
these tools allows 3DEM practitioners to mod-
ify the schema and to ensure that the model 
makes scientific sense. For the integration of the 
model into the D&A system, the model will be 
translated into the format used internally by the 
system, the Macromolecular Crystallographic 
Information File (mmCIF) format extended for 
the D&A system (PDBx)16. During the meet-
ing, many participants provided feedback on 
the draft data model. Information about the 
current version of the data model can be found 
at http://pdbe.org/emschema/.
Validation
Validation entails the assessment of errors 
and uncertainties in the results of a 3DEM 
for Electron Cryo-microscopy (CCP-EM), 
and outlined experiences gained with CCP4 
and possible synergies with CCP-EM. Three 
participants from the University of Dundee 
represented the OME team, which develops 
scientific image-file-translation libraries and 
data-management applications12,13. PDBe and 
OME work together to apply OME resources 
to 3DEM data in the EMDB, and the workshop 
was sponsored by a joint Biotechnology and 
Biological Sciences Research Council (BBSRC) 
grant that stimulates collaboration between 
groups with expertise in handling 3DEM and 
light-microscopy data. Finally, six participants 
represented the EMDataBank.
The first day of the workshop consisted of 
presentations of existing data-management 
solutions and initiatives and talks on 3DEM vali-
dation. The second day was devoted to thematic 
discussions regarding validation, segmentation, 
standards and formats, and tomography. The 
goals of the meeting were (i) to obtain feedback 
on the 3DEM data model currently being devel-
oped for EMDB; (ii) to propose concrete mea-
sures that the EMDataBank and the Worldwide 
Protein Data Bank (wwPDB14; http://wwpdb.
org) could take to aid implementation of the 
EM-VTF recommendations4 on how to improve 
the quality criteria employed in the 3DEM field 
and to ensure their widespread adoption; and 
(iii) to discuss possible models for the public 
archiving of data leading up to the final 3D map.
Outcomes
New EM data model
Since the inception of the EMDB archive at 
the European Bioinformatics Institute (EBI) in 
2002 (ref. 2), the 3DEM field has made consid-
erable progress on a number of fronts, includ-
ing electron tomography, automation and 
direct electron detectors (Fig. 2). At the same 
time, the prominence of the archive has grown 
and so has the need to link it to other relevant 
bioinformatics resources. Although the EMDB 
data model2,15 has been updated incrementally 
to accommodate these changes and address 
new requirements, it is clear that fundamental 
changes are required to the data model to keep 
up with current developments and to allow for 
future extensions and additions.
The wwPDB and the EMDataBank are 
jointly developing a new deposition and anno-
tation (D&A) system, which will facilitate the 
deposition and validation of biomacro molecular 
structure data (including X-ray crystallography, 
NMR spectroscopy, 3DEM and any combina-
tion of these techniques). The new system will 
reduce the need for manual annotation and 
improve the quality, consistency and integrity 
of the data that are entered into the archive. With 
an expected life span of at least ten years, the 
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Figure 2  Holdings of the EMDB by 3DEM technique. A representative example of each category  
is shown: single particle, human αβ-crystallin 24-mer (EMD-1894, PDB 2YGD); icosahedral, 
cytoplasmic polyhedrosis virus (EMD-5256, PDB 3IZX); helical, GMPPCP-stabilized human dynamin 1  
ΔPRD polymer (EMD-1949, PDB 3ZYS); tomogram or subtomogram average,  radial spokes from 
Chlamydomonas reinhardtii flagella (EMD-1941); 2D crystal, pig gastric H+,K+-ATPase with bound BeF 
and SCH28080 (EMD-1831, PDB 2XZB)24.
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 metadata, including the protocol, symmetry, 
mask and cutoff.
Although the issue of validating the fit of 
models to maps was not discussed in any detail 
at this meeting, it was clearly recognized as an 
area requiring more methods development. 
Currently, a basic sanity check of the fit of a 
model to a map is provided by the PDBe ‘Visual 
analysis’ pages for individual EMDB entries 
(http://pdbe.org/emd-NNNN/analysis, where 
NNNN is a four-digit EMDB accession num-
ber). These pages present orthogonal surface 
projections of the map and overlays of the map 
projections with any fitted models from the 
PDB (Fig. 3). A map-density-distribution plot 
and atom-inclusion plots for fitted models are 
also provided. The overlay of the model fitted 
to the map shows whether or not the model has 
been deposited in the same frame as the map, 
the density distribution reveals whether mask-
ing was used (the density spike at zero is often 
due to masking), and the atom-inclusion plot 
indicates whether the recommended contour 
level is reasonable.
Archiving of raw 3DEM data
Some members of the 3DEM community 
are in favor of public archiving of raw data 
much impact on the accuracy of the alignment 
and Euler-angle assignment. Another solution, 
suggested by R.H., is to use any procedure to 
obtain two reconstructions and calculate the 
FSC curve (FSCnorm) from them, then randomly 
scramble the phase information of every particle 
above a given spatial frequency, rerun the pro-
cedure and obtain a new FSC curve (FSCrand). 
If FSCrand is relatively small compared with 
FSCnorm (say <25%) in the scrambled spatial-
frequency region then one may safely assume 
that over-fitting is not an issue. However, if it 
is more significant, for example 50% or higher, 
then those who have done the test may wish to 
remove the over-fitting, for example by avoiding 
the use of high-resolution data in the refinement 
of particle orientation and position. The success 
of this more conservative approach should be 
revealed by the absence of over-fitted noise at 
high resolution when the test with random-
ized high-resolution phases is repeated. There 
are thus a number of protocols that may be 
followed in calculating the FSC curve that in 
principle are not tied to specific software pack-
ages. The EMDataBank will lead the effort to 
improve reporting standards for 3DEM valida-
tion; as a first step, the new EMDB data model 
will capture the entire FSC curve and all relevant 
that the PDBe would investigate the feasibility of 
adding support for SAXS profiles in the EM data 
model and of setting up a web service to gener-
ate simulated SAXS profiles from EM maps.
Fourier-Shell correlation (FSC)21 is the most 
commonly used method to estimate the reso-
lution of single-particle maps in EMDB. The 
shape of the FSC curve depends on the imposed 
symmetry and mask and whether or not the two 
3D reconstructions used were processed from 
a common reference. The resolution estimated 
from the curve depends critically on the thresh-
old criterion used. Ideally, an FSC curve is based 
on two completely independent reconstructions 
with all relevant variables, including the proto-
col, symmetry, mask and cutoff, clearly specified. 
In practice, this means calculating two indepen-
dent reconstructions, each from separate halves 
of the recorded data. However, using only half 
the particles may substantially compromise the 
achievable  resolution. An alternative is to low-
pass filter the data to a resolution threshold, say 
15 Å, for image processing and to re-introduce 
the filtered-out  information for FSC calculation. 
Information at spatial frequencies above the res-
olution threshold will not be affected by refer-
ence bias, and the loss of information owing to 
low-pass filtering would not be expected to have 
Figure 3  Visual analysis of EMDB entries. Visual analysis page for EMDB entry EMD-1831 (http://pdbe.org/emd-1831/analysis), the structure of  
pig gastric H+,K+-ATPase with bound BeF and SCH28080 (ref. 24). The top right panel presents orthogonal surface projections of the map. The bottom 
right panel displays orthogonal surface projections of the map overlaid with the fitted PDB model 2XZB (green, all atoms; blue, backbone only). The 
chart on the top left shows the histogram of density values, and the one below shows the fraction of model atoms contained in the map as a function of 
contour level (red line, recommended level).
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software packages and the deposition of data in 
public archives. There was a community-wide 
effort in 2004 to define such conventions (http://
rcsb-cryo-em-development.rutgers.edu/), and 
although some packages have adopted these to 
various degrees, many of the major ones have 
not. In many cases, developers have legitimate 
reasons for adopting proprietary formats; hav-
ing already implemented a lot of routines using 
these formats, they find little to be gained by 
making a change. As highlighted by J.R.S., the 
experience in the light-microscopy field has 
been that it is not sufficient to simply define 
standards and conventions and that one also 
has to provide the community with the neces-
sary software libraries to allow data conversion 
to and from the convention standard13. The 
OME has done so with the BioFormats library 
(http://www.openmicroscopy.org/site/support/
bio-formats/), which now also supports sev-
eral 3DEM formats, including Spider (http://
www.wadsworth.org/spider_doc/spider/docs/
image_doc.html), Imagic (http://www.imag-
escience.de/formats.html) and MRC (http://
www2.mrc-lmb.cam.ac.uk/image2000.html). 
Also, as J.B.H. argued, validation tools to 
examine map parameters, to assess map sym-
metry and to check orientation conversions are 
essential to ensure accurate translation of data 
formats. The EMDataBank will set up a portal 
to provide access to such tools and will promote 
the development of new tools.
J.B.H. proposed a new map format that would 
be able to deal with up to five- dimensional 
data (channels, x, y, z and volumes) and would 
not be limited by the legacy issues that plague 
other formats (often derived from the CCP4 
map format (http://www.ccp4.ac.uk/html/
maplib.html#description) used in macro-
molecular crystallography). However, some 
participants argued that compatibility with 
CCP4 was a requirement. M.W. suggested 
that the 3DEM community should not be hin-
dered by the requirements of the X-ray com-
munity in defining its formats. This is partly 
because  crystallographers increasingly store 
map co efficients and compute maps on the 
fly, which reduces the importance of maps and 
map  formats. No consensus was reached on this 
issue, but the recent CCP-EM initiative, with 
its close ties to CCP4 and the Collaborative 
Computing Project for NMR (CCPN)23, 
provides an opportunity to develop a format 
acceptable to 3DEM developers and supported 
by relevant crystallography software.
From the perspective of the EMDataBank and 
the wwPDB, there is an urgent need to resolve 
issues around standards and conventions in 
order to incorporate 3DEM validation methods 
into the D&A pipeline. It was generally agreed 
that the participants would adapt their  software 
storage efficiency). In the face of a wide variety 
of storage options, participants agreed that the 
PDBe will draft a specification as the basis for 
communitywide discussion involving all soft-
ware developers, the EMDataBank, and others.
Tomography
Although single-particle reconstruction relies 
on averaging information from a large number 
of molecules, electron tomography, in which a 
series of images is collected from a specimen 
region at different tilt angles, can be used to 
obtain 3D reconstructions of individual macro-
molecules and to study the 3D organization of 
macromolecular complexes and organelles in 
their native environment in the cell. 3D single-
particle computational methods can also be 
applied in the context of a tomogram to obtain 
subtomogram averages at a higher resolution 
than the tomogram itself.
The number of tomograms deposited in 
the EMDB is much lower than the num-
ber published; in a survey by the PDBe of 
 tomography-related journal publications for 
the period 2006–2010, only 14% were found 
to have associated depositions to the EMDB 
archive. This is because of a lack of  consensus 
in the tomography community as to the need 
for deposition and the current EMDB data 
model that inadequately describes the idio-
syncrasies of the technique, for example fail-
ing to distinguish between tomograms and 
subtomogram averages. Although the latter 
issue is addressed in the new EMDB data 
model, the former is not so easily resolved. 
The EMDataBank will engage the tomo-
graphy community on this issue by organizing 
thematic discussion sessions at 3DEM-related 
meetings such as the 3DEM Gordon Research 
Conference and the International Congress on 
Electron Tomography.
The issue of whether cellular tomograms 
should be archived in the EMDB was also dis-
cussed. It is difficult to define a sharp threshold 
(for example, based on size or complexity) to 
distinguish between macromolecular and cel-
lular tomographic reconstructions. Therefore, 
it was recommended that no such distinction 
be made at this time and that the EMDB should 
continue to accommodate both types of recon-
structions. This means that the new EMDB 
data model will need to handle annotations 
relevant for both types of tomography. For 
instance, a molecular description of a sample 
may not be possible or make sense in cellular 
tomography, and specimen-preparation tech-
niques differ.
Standards and conventions
Community-wide standards and conventions 
are important for the exchange of data between 
 associated with a reconstructed map, for 
example the raw 2D image data or all the inter-
mediate steps, files and parameters to achieve 
a full ‘electronic notebook’ of a 3DEM experi-
ment. These data could be used to validate 
the final map, and software developers could 
use them to test new algorithms. Moreover, 
deposited raw data could be reprocessed in the 
future, for example to a higher resolution, by 
using improved image-processing techniques 
or (especially in the case of tomo graphy) 
a different focus compared to the original 
deposition. Some meeting participants were 
positively inclined toward the idea of raw-data 
storage. However, several of the participants 
were more cautious, on the basis of their own 
experiences with local archives. They suggest 
that the challenge of archiving raw data on 
a global scale—in terms of storage require-
ments, the logistics of moving data around 
and especially the cost and effort of manual 
annotation—could prove to be prohibitively 
expensive. In tomography, there are projects 
that generate 100 gigabytes–1 terabyte of both 
raw data and final reconstructions. J.R.S. sug-
gested that the 3DEM community might be 
interested in how the light-microscopy com-
munity has addressed similar problems, for 
example by using the Journal of Cell Biology 
(JCB) DataViewer22.
There was a consensus that routine depo-
sition of raw data to the EMDB is premature 
but that it would be useful to set up a test-
image database of particle images used in 
single-particle processing and tilt series used 
in tomography. The PDBe and the OME will 
use OMERO12 to set up such a database. The 
database will provide test data for development 
work and enable investigation of the many 
issues surrounding raw-data archiving high-
lighted above. Several meeting participants, 
including B.C.and G.J.J., agreed to contribute 
data to this resource.
Segmentation
Segmentation is the process of dividing a map 
into regions that may or may not overlap and to 
which, ideally, biologically relevant identifica-
tions or annotations can be assigned. The new 
EMDB data model will improve the handling 
of segmentations and annotations. An over-
view presented by S.J.L. at the meeting showed 
that no single method for representing map 
segmentations was superior in all respects, 
and comparable levels of compression could be 
achieved by all binary segmentation represen-
tations. Some methods can handle overlapping 
regions, and some require a separate file for 
each segment, whereas others can store all seg-
ments in one file, and only a few support non-
binary segmentation (usually at the expense of 
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· The EMDataBank will lead the effort to 
define and promote standards and con-
ventions for 3DEM.
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and practices to standards proposed and 
adopted by the EMDataBank and that therefore 
EMDataBank should lead this initiative. 
Conclusions
· The PDBe will investigate the use of SAXS 
data for 3DEM map validation.
· The EMDataBank will lead the effort to 
improve reporting standards for 3DEM 
validation and begin by providing a com-
prehensive description of the FSC method 
in the new EMDB data model.
· The PDBe and OME will use OMERO to 
set up a test-image database for 3DEM.
· The EMDataBank will lead the effort to 
develop a segmentation file format with 
the 3DEM community.
· The EMDataBank will engage with the 
electron-tomography community to 
resolve issues surrounding the deposition 
of tomographic data to the EMDB archive.
· The EMDataBank will set up a portal to 
provide access to validation tools and will 
promote the development of new ones.
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